Literature DB >> 16125658

Optimal combined approaches of field intervention for schistosomiasis control in China.

Dan-Dan Lin1, Guang-Han Hu, Shao-Ji Zhang.   

Abstract

Before the mid 1980s, the emphasis in schistosomiasis control in China was on transmission control. Thus, the aim was to eliminate the intermediate host snail by environmental management, combined with chemotherapy, water supply and sanitation, and hygiene improvement. During the last 20 years, however, control approaches mainly consisting of large-scale praziquantel-based chemotherapy and health education started to be advocated and also increasingly applied. Here, we review the literature with an emphasis on combined approaches of field interventions that have been implemented for schistosomiasis control in China over the past 50 years. The interventions consist of both pilot studies and large-scale implementation during different historical periods. The feasibility and effectiveness of the various combined approaches are examined and analysed in relation to local economic conditions and the prevailing scientific and technical expertise. Finally, a set of recommendations is put forward for contemporary schistosomiasis control readily adapted to different eco-epidemiological settings in China.

Entities:  

Mesh:

Year:  2005        PMID: 16125658     DOI: 10.1016/j.actatropica.2005.07.018

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  9 in total

Review 1.  History of Human Schistosomiasis (bilharziasis) in China: From Discovery to Elimination.

Authors:  Yibiao Zhou; Yue Chen; Qingwu Jiang
Journal:  Acta Parasitol       Date:  2021-03-13       Impact factor: 1.440

2.  In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.

Authors:  Poppy H L Lamberton; Sarah C Hogan; Narcis B Kabatereine; Alan Fenwick; Joanne P Webster
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

3.  Performance of a dipstick dye immunoassay for rapid screening of Schistosoma japonicum infection in areas of low endemicity.

Authors:  Jing Xu; Ting Feng; Dan-Dan Lin; Qi-Zhi Wang; Li Tang; Xiao-Hua Wu; Jia-Gang Guo; Rosanna W Peeling; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2011-05-20       Impact factor: 3.876

4.  Changing patterns of spatial clustering of schistosomiasis in Southwest China between 1999-2001 and 2007-2008: assessing progress toward eradication after the World Bank Loan Project.

Authors:  Yi Hu; Chenglong Xiong; Zhijie Zhang; Can Luo; Ted Cohen; Jie Gao; Lijuan Zhang; Qingwu Jiang
Journal:  Int J Environ Res Public Health       Date:  2014-01-03       Impact factor: 3.390

Review 5.  Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China.

Authors:  Yi-Biao Zhou; Song Liang; Qing-Wu Jiang
Journal:  Parasit Vectors       Date:  2012-12-03       Impact factor: 3.876

Review 6.  Large-scale preventive chemotherapy for the control of helminth infection in Western Pacific countries: six years later.

Authors:  Antonio Montresor; Dai Tran Cong; Mouth Sinuon; Reiko Tsuyuoka; Chitsavang Chanthavisouk; Hanne Strandgaard; Raman Velayudhan; Corinne M Capuano; Tuan Le Anh; Ah S Tee Dató
Journal:  PLoS Negl Trop Dis       Date:  2008-08-27

7.  Ecological Model to Predict Potential Habitats of Oncomelania hupensis, the Intermediate Host of Schistosoma japonicum in the Mountainous Regions, China.

Authors:  Hong-Ru Zhu; Lu Liu; Xiao-Nong Zhou; Guo-Jing Yang
Journal:  PLoS Negl Trop Dis       Date:  2015-08-25

8.  Control efficacy of annual community-wide treatment against Schistosoma japonicum in China: a meta-analysis.

Authors:  Jing Su; Da-Bing Lu; Xia Zhou; Su-Rong Wang; Hong-Xiang Zhuge
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

9.  Sensitivity of Oncomelania hupensis to niclosamide: a nation-wide survey in China.

Authors:  Jianrong Dai; Youzi Li; Wei Wang; Yuntian Xing; Guoli Qu; Yousheng Liang
Journal:  Int J Environ Res Public Health       Date:  2014-03-12       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.